The RAS-RAF-MAPK ERK kinase (MEK)-ERK pathway is a major determinant in the control of diverse cellular processes such as proliferation, survival, differentiation and motility, which controls cell survival and proliferation in NSCLC [43]. The gene discussed is MAP2K7; the disease is non-small cell lung carcinoma.